Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App





DiaSys Showcases High Quality Diagnostic Reagents and System Solutions

By LabMedica International staff writers
Posted on 14 Nov 2023

DiaSys Diagnostic Systems GmbH (Holzheim, Germany) is presenting its comprehensive portfolio of clinical chemistry analyzers, reagents, calibrators and controls at MEDICA 2023. More...

DiaSys offers complete system solutions including analyzer, reagents, and software. At MEDICA 2023, DiaSys is highlighting the respons910 benchtop analyzer which has a throughput of 100 to 150 tests/hour and is ideal for laboratories with a test volume of up to 500 tests per shift. Its high onboard capacity of 30 different methods in mono- or twin-containers and 30 sample positions offers the necessary flexibility for everyday use. Alongside the respons910, DiaSys is showcasing the respons920 benchtop analyzer with higher speed and guaranteed throughput of 200 tests/h and 360 tests/hour with ISE. With an on-board capacity of 30 different methods in mono- or twin containers, 30 samples plus nine positions for calibrators, controls, or emergency samples, respons920 offers almost unlimited flexibility in organizing laboratory workflows.

DiaSys is also highlighting the respons940 automated random access clinical chemistry analyzer that offers a constant throughput of a minimum of 400 tests/h, independent of whether a mono- or two-component reagent is used. Together with modern software features, pre-programmed applications, and carry-over evasion lists, respons940 analyzer delivers high-quality results for a broad parameter portfolio. Among the company’s products being highlighted at the show is the DiaSys CRP FS liquid-stable immunoturbidimetric test with dedicated ready-to-use calibrators and controls that allow true differentiation of borderline cases. DiaSys has extended its cardiovascular risk assessment portfolio with two innovative new reagents, HDL-c direct FS and LDL-c direct FS. Both are homogenous assays for direct determination. DiaSys has also expanded the application range for its Total bile acids 21 FS reagent and now offers the assay for use in serum and stool samples.

Related Links:
DiaSys Diagnostic Systems


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.